(Q50719207)

English

The cost-burden of paediatric pneumococcal disease in the UK and the potential cost-effectiveness of prevention using 7-valent pneumococcal conjugate vaccine

scientific article published on June 2, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/12744892

The cost-burden of paediatric pneumococcal disease in the UK and the potential cost-effectiveness of prevention using 7-valent pneumococcal conjugate vaccine (English)

1 reference

10.1016/S0264-410X(03)00031-8

https://api.crossref.org/works/10.1016/S0264-410X(03)00031-8

2 January 2024

pneumococcal conjugate vaccine

1 reference

based on heuristic

inferred from title

molecular medicine

1 reference

10.1016/S0264-410X(03)00031-8

https://api.crossref.org/works/10.1016/S0264-410X(03)00031-8

2 January 2024

author name string

Peter Conway

2

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/12744892

Julie Willingham

3

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/12744892

Adam Lloyd

4

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/12744892

E. David G. McIntosh

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12744892

2 January 2024

language of work or name

0 references

publication date

1 June 2003

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/12744892

2 June 2003

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12744892

2 January 2024

full work available at URL

https://api.elsevier.com/content/article/PII:S0264410X03000318?httpAccept=text/xml

1 reference

10.1016/S0264-410X(03)00031-8

https://api.crossref.org/works/10.1016/S0264-410X(03)00031-8

2 January 2024

https://api.elsevier.com/content/article/PII:S0264410X03000318?httpAccept=text/plain

1 reference

10.1016/S0264-410X(03)00031-8

https://api.crossref.org/works/10.1016/S0264-410X(03)00031-8

2 January 2024

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/12744892

21

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/12744892

19-20

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/12744892

2564-2572

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/12744892

Epidemiology of invasive and other pneumococcal disease in children in England and Wales 1996-1998.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900031-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900031-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900031-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900031-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900031-8

7 January 2021

based on heuristic

inferred from DOI database lookup

New rapid antigen test for diagnosis of pneumococcal meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900031-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Community-acquired pneumonia: the annual cost to the National Health Service in the UK.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900031-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibody concentration and clinical protection after Hib conjugate vaccination in the United Kingdom.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900031-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Invasive pneumococcal disease in England and Wales: what is the true burden and what is the potential for prevention using 7 valent pneumococcal conjugate vaccine?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900031-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes of bacterial meningitis in children: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900031-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term sequelae of pneumococcal meningitis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900031-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Pneumococcal conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900031-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Haemophilus influenzae type b carriage and immunity four years after receiving the Haemophilus influenzae oligosaccharide-CRM197 (HbOC) conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900031-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Observed costs and health care use of children in a randomized controlled trial of pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900031-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900031-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of febrile children in the age of the conjugate pneumococcal vaccine: a cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900031-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0264-410X(03)00031-8

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/12744892

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 March 2018

http://europepmc.org/abstract/MED/12744892

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50719207&oldid=2042948753"